Skip to main content

Table 2 Univariate and multivariate analysis for overall survival

From: Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma

Variables Univariate Multivariate
5-years OS P-value HR (95 % CI) P-value
Sex (Male vs. Female) 63 % vs. 52 % 0.553   
Age (≥20 vs. <20) 60 % vs. 57 % 0.871   
Tumor size (≥5 cm vs. <5 cm) 53 % vs. 65 % 0.136   
Histologic type (Epi. Sarcoma vs. Others) 18 % vs. 63 % 0.004 1.459 (0.414–5.137) 0.556
Tumor location (Axial vs. Extremity) 57 % vs. 63 % 0.423   
Initial metastasis (Yes vs. No) 33 % vs. 65 % 0.034 2.335 (0.858–6.351) 0.097
Surgery (Yes vs. No) 62 % vs. 40 % 0.069   
Margin status (Positive vs. Negative) 51 % vs. 62 % 0.819   
Adjuvant therapy (Yes vs. No) 58 % vs. 65 % 0.921   
PD-L1 expression (Yes vs. No) 48 % vs. 68 % 0.015 2.490 (1.032–6.007) 0.042
  1. HR hazard ratio, CI confidence interval